270 related articles for article (PubMed ID: 18398704)
1. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
Baudouin C; Riancho L; Warnet JM; Brignole F
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
[TBL] [Abstract][Full Text] [Related]
4. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
[TBL] [Abstract][Full Text] [Related]
5. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
[TBL] [Abstract][Full Text] [Related]
9. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
10. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
Whitson JT; Petroll WM
Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
[TBL] [Abstract][Full Text] [Related]
11. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells.
Kahook MY; Ammar DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):259-63. PubMed ID: 20565312
[TBL] [Abstract][Full Text] [Related]
12. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
[TBL] [Abstract][Full Text] [Related]
13. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone eye drop-induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis.
Dutot M; Pouzaud F; Larosche I; Brignole-Baudouin F; Warnet JM; Rat P
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2812-9. PubMed ID: 16799018
[TBL] [Abstract][Full Text] [Related]
15. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
[TBL] [Abstract][Full Text] [Related]
17. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C
Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577
[TBL] [Abstract][Full Text] [Related]
18. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
Ammar DA; Kahook MY
Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
[TBL] [Abstract][Full Text] [Related]
19. Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost.
Pellinen P; Lokkila J
Ophthalmic Res; 2009; 41(2):118-22. PubMed ID: 19147999
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
Kahook MY; Noecker R
Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
